MORPHOMETRIC ANALYSIS OF MICROGLIA IN ALZHEIMERS-DISEASE

被引:85
|
作者
CARPENTER, AF
CARPENTER, PW
MARKESBERY, WR
机构
[1] UNIV KENTUCKY,MED CTR,DEPT PATHOL,101 SANDERS BROWN BLDG,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,MED CTR,DEPT NEUROL,LEXINGTON,KY 40536
[3] UNIV KENTUCKY,MED CTR,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536
关键词
ALZHEIMERS DISEASE; COMPUTERIZED MORPHOMETRIC IMAGE ANALYSIS; LN3; IMMUNOCYTOCHEMISTRY; MICROGLIA;
D O I
10.1097/00005072-199311000-00007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
HLA-DR-immunoreactive microglia were quantitated in the middle temporal gyrus of five late-stage patients with Alzheimer's disease (AD) and five age-matched control subjects using LN3 immunocytochemistry and computerized morphometric image analysis. The grand mean numerical density of HLA-DR-immunoreactive microglia in AD (403.86/mm2) was significantly larger than in the five control subjects (193.33/mm2) (p < 0.000 1). The grand mean cross-sectional area of HLA-DR-immunoreactive microglia in AD subjects (222.90 mum2) was significantly larger than in control subjects (121.59 mum2) (p < 0.0001). The percentage of total microglia that were large activated microglia was much greater in AD (47.9%) than in control subjects (15.2%). The grand mean percent of the cortical area occupied by HLA-DR-immunoreactive microglia in AD (9.02%) was significantly greater than in controls (2.35%) (p < 0.0001). Microglia were present in greater numbers in the outer three cortical laminae in both AD and controls. The striking increase in activated microglia in the neocortex and their role in the inflammatory response and possible secretion of neurotoxins could be important in neuron degeneration in AD.
引用
收藏
页码:601 / 608
页数:8
相关论文
共 50 条
  • [31] ALZHEIMERS-DISEASE
    SMITH, CM
    SWASH, M
    STRESS MEDICINE, 1985, 1 (04): : 269 - 277
  • [32] ALZHEIMERS-DISEASE
    KRETSCHMAR, C
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1985, 127 (42): : 986 - 988
  • [33] ALZHEIMERS-DISEASE
    KATZMAN, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (15): : 964 - 973
  • [34] ALZHEIMERS-DISEASE
    不详
    BRITISH MEDICAL JOURNAL, 1980, 281 (6252): : 1374 - 1375
  • [35] ALZHEIMERS-DISEASE
    HYMAN, BT
    DAMASIO, H
    DAMASIO, AR
    VANHOESEN, GW
    ANNUAL REVIEW OF PUBLIC HEALTH, 1989, 10 : 115 - 140
  • [36] ALZHEIMERS-DISEASE
    CORKIN, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (8A): : 957 - 960
  • [37] ALZHEIMERS-DISEASE
    HUTTON, JT
    TEXAS MEDICINE, 1987, 83 (01) : 6 - 7
  • [38] ALZHEIMERS-DISEASE
    RICH, V
    CHEMISTRY IN BRITAIN, 1989, 25 (10) : 992 - 992
  • [39] ALZHEIMERS-DISEASE
    SISKIND, JG
    SOCIAL WORK, 1986, 31 (05) : 415 - 415
  • [40] ALZHEIMERS-DISEASE
    GABRIEL, YH
    WISCONSIN MEDICAL JOURNAL, 1980, 79 (05): : 9 - 9